Malignant Male Genital Tract and Urinary System Tumours: Tumour Registry Data Analysis at Armed Forces Institute of Pathology, Pakistan (2009-2018)

Objective: To study the frequency and distribution of malignancies of the male genital tract and urinary system. Study Design: Retrospective longitudinal study. Place and Duration of Study: Histopathology Department, Armed Forces Institute of Pathology, Rawalpindi Pakistan, fromJan 2009 to Dec 2018. Methodology: Two thousand four hundred thirteen cases of malignant tumours of the male genital tract and 4278 cases of tumours of the urinary system were extracted from the tumour registry of the Armed Forces Institute of Pathology (AFIP). Results: Thirty-seven thousand seven hundred ninety-three malignant cases were reported at AFIP from 2009-2018, in which 2413(6.38%) were of the male genital tract and 4278(11.32%) were of the Urinary system. The most frequent tumour out of these was carcinoma prostate 2024(83.8%), followed by tumours of testis 359(14.8%), penis 7(0.3%) and MGT tumours (NOS).In the urinary system, bladder cancers were most frequently seen 3289(78%), followed by kidney tumours 989(22%). Bladder cancer was the top most and prostate cancer was the second most common tumour in males in the seventh decade (60-69 years). Kidney tumours were the third most common in female children in the first decade, following eye and lymph node malignancies. Conclusion: Carcinoma prostate was the most frequent male genital tract cancer, followed by the testicular tumour. In the urinary system, bladder cancers were most frequently reported with male predominance followed by kidney tumours.